Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A6 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
GEO DataSets Gene Profile neighbors Homologene neighbors
GCFC2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FANCI - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
C10orf88 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
ETFA - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
CDK17 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
SDCBPP2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTPN22 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
RXRB - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
ZNF207 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
MED16 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
PDXK - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
CAMK2D - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
PPT1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
PTP4A1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
CREBL2 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
FAM26F - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
ITGB1 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
CXCR4 - Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on